Navigation Links
According to Opurity, Feds Put U.S. Consumers at Risk: PTO Bureaucrats Refuse to Approve Vitamin Company's 'China-Free' Trademark
Date:10/19/2010

STERLING, Va., Oct. 19 /PRNewswire/ -- In an astounding case of callous disregard for U.S. consumers, the U.S. Patent and Trademark Office (PTO) has denied registration of the trademark "China-Free"* submitted by the manufacturer of Opurity vitamins, who simply wishes to provide customers with an informed choice for obtaining vitamins containing no ingredients from China.

Trademark registration was refused because it was deemed to be "disparaging" to China and promoted a "stereotype that all Chinese manufacturers make poor quality goods."

"The PTO made a subjective and arbitrary decision in denying our trademark," said Jerome Krachenfels, executive vice president of ProSynthesis Laboratories, Inc. owner of Opurity Vitamins.  "We're not saying that all products from China are shoddy, but there are numerous recent examples of contaminated, counterfeit, adulterated and dangerous products coming from China."  The problem is serious enough that FDA head Margaret Hamburg traveled to China last month to address the safety of goods coming into the U.S.

"So we want to establish via a trademark that none of the ingredients in our vitamins are from China," Mr. Krachenfels said.  "Consumers should have the best opportunity to understand what they're buying for a product as critical to health as vitamins."  In an IBM survey last year, 75 percent of consumers clearly expressed a desire to know the origin of their food. 

Even in its decision, the PTO admitted that "recent newsworthy events have highlighted that [some] Chinese manufacturers do not make quality products..."   The ruling was that much more of a surprise as the PTO's initial notice had indicated registration was unobjectionable other than asking for a technical correction to the application.  According to Opurity's attorney, the spontaneous rescission was highly unusual, smacking of some type of extraordinary intervention at a higher level.

Opurity is the first, and currently the only, company in the vitamin industry to make the guarantee: "No Ingredients from China."

"It's been a challenging two years to get to where we can actually make that guarantee," said Mr. Krachenfels, "because a high percentage of vitamin ingredients are from China." "We are open about where our ingredients and raw materials come from.  We don't see the same openness from other vitamin companies."  

"Opurity is a classic American small business working to give consumers a better safer product without ingredients from a source that continues to be risky.." Mr. Krachenfels said.  "At times it seems that the Obama Administration cares more about placating and kowtowing to China than protecting its own citizens.  We've felt like David going up against Goliath China, but with the PTO's refusal, now we're struggling with our own government.  It's the consuming public who will be the real loser if this unwarranted decision stands."

The company has vowed to appeal the denial. "We'll go as far as we have to go to right this wrong," a determined Mr. Krachenfels said.  "The public interest demands it."

ProSynthesis Laboratories was founded in 2002 by Mr. Krachenfels and his wife Martha M. Krachenfels, MS RD, who holds an MS in clinical nutrition.  The company began marketing its Opurity line of vitamins in 2010.

*The trademark includes a diamond between the two words.


'/>"/>
SOURCE Opurity
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
2. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
3. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
4. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
5. New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry
6. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
7. Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
8. Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc.
9. Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
10. Microplate Instrumentation & Supplies Market to Exceed $5.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc
11. Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):